Dr. Reddy’s to buy Mayne Pharma’s US generic prescription product portfolio
Indian pharmaceutical firm Dr. Reddy’s Laboratories has signed a definitive agreement with Australia-based Mayne Pharma Group to acquire the latter’s US generic prescription product portfolio. Under the terms